Champions Oncology, Inc. (CSBR) vs Verrica Pharmaceuticals Inc. (VRCA)
A side-by-side comparison of Champions Oncology, Inc. and Verrica Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VRCA
Verrica Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CSBR vs VRCA
growth of $100 · dividends reinvested · last 8yCSBR -13.3% (-1.8%/yr)VRCA -97.5% (-37.1%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CSBR VRCA
CSBR vs VRCA: by the numbers
- •VRCA is the larger company ($72M vs $70M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -102.84% net margin).
- •VRCA grew revenue faster over the past five years (20.37% vs 7.25% CAGR).
Metrics side by side
Valuation
| Metric | CSBR | VRCA |
|---|---|---|
| Forward P/E | 50.10 | N/A |
| P/S ratio | 1.15 | 2.39 |
| P/B ratio | 17.88 | 16.79 |
| EV / EBITDA | 261.92 | N/A |
Profitability
| Metric | CSBR | VRCA |
|---|---|---|
| Gross margin | 49.30% | 85.89% |
| Operating margin | -1.72% | -33.56% |
| Net margin | -1.87% | -102.84% |
| ROE | -29.15% | -724.01% |
| ROIC | -6.75% | -207.23% |
Growth (annualized)
| Metric | CSBR | VRCA |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | 20.37% |
| Total return CAGR (5Y) | -13.07% | -48.68% |
Frequently asked
- Which has grown faster, CSBR or VRCA?
- Over the past five years, VRCA grew revenue faster — CSBR at a 7.25% CAGR versus VRCA at 20.37%.
- How have CSBR and VRCA total returns compared?
- Over the past 5 years, CSBR delivered -13.07% and VRCA delivered -48.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Champions Oncology ROEVerrica Pharmaceuticals ROEChampions Oncology operating marginVerrica Pharmaceuticals operating marginChampions Oncology revenue growthVerrica Pharmaceuticals revenue growthChampions Oncology free cash flowVerrica Pharmaceuticals free cash flow
Champions Oncology & Verrica Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.